E S Anton1, 8, H T Ghashghaei1, 8, Janet L Weber2, Corey McCann1, Tobias M Fischer2, Isla D Cheung2, Martin Gassmann3, Albee Messing4, Rudiger Klein5, Markus H Schwab2, 6, K C Kent Lloyd7
& Cary Lai21
UNC Neuroscience Center and the Department of Cell and Molecular Physiology, The University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA.
2
Department of Neuropharmacology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California 92037, USA.
3
Department of Physiology, Biozentrum/Pharmazentrum, University of Basel Klingelbergstr. 50, CH-4056 Basel, Switzerland.
4
Waisman Center on Mental Retardation & Human Development, University of Wisconsin-Madison, Madison, Wisconsin 53705-2280, USA.
5
Max-Planck-Institut für Neurobiologie, Am Klopferspitz 18A, 82152 Martinsried, Germany.
6
Max-Planck-Institut für Experimentelle Medizin, Hermann−Rein−Str. 3, 37075 Göttingen, Germany.
7
Center for Comparative Medicine, School of Veterinary Medicine, University of California, Davis, One Shields Avenue, Davis, California 95616, USA.
8
These authors contributed equally to this work.
Correspondence should be addressed to E S Anton anton@med.unc.edu
